JP
LinkedIn

John Pedersen

Chairman Of The Board

Steamboat Springs, Colorado, United States · 1 connection

DYSIS Medical

Not on Unlinked · Imported profile. Is this you? Claim it

About

John Pedersen is currently Chairman of the Board of Dysis Medical. Previously he was CEO of Augmenix. John joined Augmenix as CEO in 2014 and sold the company for $600M to Boston Scientific in 2018. Previously he was a Senior Healthcare Advisor for two Healthcare Private Equity Funds – The Gores Group and The Pritzker Group. He served on the Board of Directors of Therakos and Clinical Innovations, two privately held medical device companies. Prior to this, John was President of the Urology and Women’s Health Division at Boston Scientific. During his 15 years at Boston Scientific, he also served as President of the Peripheral Interventions and the Neurovascular Divisions. Prior to Boston Scientific, he was a Senior Engagement Manager at McKinsey & Co. John earned an MBA from The Harvard Graduate School of Business Administration and an AB degree from Princeton University.

Experience

Chairman Of The BoardDYSIS Medical
Jan 2020 to Aug 2024
Chief Executive OfficerAugmenix, Inc.
Dec 2014 to Apr 2019
Senior AdvisorPritzker Group
Jan 2013 to Oct 2017
Board MemberLaborie
Dec 2012 to Oct 2017
Health Care AdvisorThe Gores Group
Feb 2013 to Feb 2015
President Urology and Women's Health, SVP Boston ScientificBoston Scientific
Feb 2010 to Mar 2012
President, Peripheral InterventionsBoston Scientific
Jul 2005 to Dec 2007
President, Urology and GynecologyBoston Scientific
Feb 2001 to Jun 2005
President, NeuroVascularBoston Scientific
Jan 1998 to Feb 2001
Director of New Business DevelopmentBoston Scientific
Sep 1996 to Jan 1998
Senior Engagement ManagerMcKinsey & Company
May 1991 to Sep 1996
Associate ConsultantCapgemini Invent
Oct 1986 to Jul 1989

Education

Harvard Business School
MBA Finance Operations
1989 to 1991
Princeton University
AB History
1981 to 1985
Loch Raven High School